Recent Updates
Recently added Catalysts
MDXG Positive Sentiment

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

Key Takeaway: MiMedx Group, Inc. will announce its operating and financial results for Q1 2024 on April 30, following market closure. A conference call to discuss these results will take place at 4:30 p.m. ET on the same day. The event will be accessible to both U.S. and international investors, with a replay available for 30 days post-event. MIMEDX continues to focus on innovation in wound care and aims to enhance quality of life through its products.
Price reaction · baseline $6.35 (2024-04-15 close) · hit after-hours · clean, no other MDXG news in the window
day 0 close · peak
-1.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • MIMEDX is set to release its financial results, indicating active business operations.
  • The company's focus on innovation in wound care suggests a commitment to improving healthcare.
  • MIMEDX has established itself as a leader in the management of chronic wounds.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~40 mo
Low dilution risk
Lead asset
Micronized DHACM
Phase 3 · Tendonitis;Achilles

Full Press Release Details

MARIETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it will report its operating and financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, April 30, 2024. The MIMEDX senior management team will host a webcast and conference call to review its results beginning at 4:30 p.m. Eastern Time on the same day.
The conference call can be accessed using the following information:
U.S. Investors: 877-407-6184
International Investors: 201-389-0877
Conference ID: 13745475
A replay of the webcast will be available for approximately 30 days on the Company’s website at www.mimedx.com following the conclusion of the event.
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Frequently Asked Questions

When will MiMedx report its 2024 Q1 results?

MiMedx will report its Q1 results on April 30, 2024, after market close.

What time is the conference call on April 30, 2024?

The conference call is scheduled for 4:30 p.m. Eastern Time.

How can I access the conference call?

U.S. investors can call 877-407-6184; International investors can call 201-389-0877.

Will there be a replay of the webcast?

Yes, a replay will be available for about 30 days on MiMedx's website.

What does MiMedx specialize in?

MiMedx specializes in products for wound care, burns, and surgical applications.

Last updated: Apr 16, 2024